4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-002379
Director sold 10,000 shares at an average $57.34 ($573,369)
- Director acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
DOBMEIER ERIC · Director
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-01-04 | Exercise or conversion : show line 1 in the form | +10,000 | $6.32 | $63,200 | 10,000 | D |
| 2021-01-04 | Sale : show line 2 in the form | −3,283 | $56.10 | $184,176 | 6,717 | D |
| 2021-01-04 | Sale : show line 3 in the form | −5,725 | $57.76 | $330,676 | 992 | D |
| 2021-01-04 | Sale : show line 4 in the form | −592 | $58.67 | $34,733 | 400 | D |
| 2021-01-04 | Sale : show line 5 in the form | −400 | $59.46 | $23,784 | 0 | D |
| Open-market sales · 10,000 sh · avg $57.34 · $573,369 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-01-04 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −10,000 | 35,000 | D |
Loading xslF345X03/doc4.xml…